Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 January 1996 | Volume 124 Issue 1 Part 1 | Pages 35-40
New vaccines have been licensed for hepatitis A, varicella, and typhoid.This paper reviews these vaccines and their recommended uses in adults. Special attention is given to a new national policy establishing age 50 years as a time for review of preventive health measures with emphasis on evaluating risk factors that indicate a need for pneumococcal vaccine and the initiation of annual influenza immunization.
Author and Article Information
From the State University of New York at Stony Brook, Stony Brook, New York; University of Colorado Health Sciences Center, Denver, Colorado; Mayo Clinic and Foundation, Rochester, Minnesota; Hackensack Medical Center, Hackensack, New Jersey; Vanderbilt University School of Medicine, Nashville, Tennessee; University of Rochester School of Medicine and Dentistry, Rochester, New York; and the Centers for Disease Control and Prevention, Atlanta, Georgia.
UPDATE
Adult Immunizations
![]()
Acknowledgments: The authors thank Linda Johnson White and Bobbie Lewis, of the American College of Physicians, for their assistance.
Requests for Reprints: Pierce Gardner, MD, Associate Dean for Academic Affairs, School of Medicine, State University of New York at Stony Brook Health Sciences Center, Stony Brook, NY 11794-8432.
Current Author Addresses: Dr. Gardner: School of Medicine, State University of New York at Stony Brook Health Sciences Center, Stony Brook, NY 11794-8432.
This article has been cited by other articles:
![]() |
B. L. Atkins, T. Gottlieb, J. Licciardone, R. Gleckman, and J. M. Zenilman Emerging Drug Resistance and Vaccination for Typhoid Fever JAMA, February 25, 1998; 279(8): 579 - 580. [Full Text] [PDF] |
||||